CG Oncology, Inc.
Ticker: 1991792
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q1 FY25 | Q3 FY24 | Q2 FY24 | Q2 FY24 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 1.60+37.9% | 1.16+7.4% | 1.08-35.3% | 1.67+3240.0% | 0.05+25.0% | 0.04-63.6% | 0.11+0.0% | 0.11 |
| Total Income | 1.60+37.9% | 1.16+7.4% | 1.08-35.3% | 1.67+3240.0% | 0.05+25.0% | 0.04-63.6% | 0.11+0.0% | 0.11 |
| EXPENSES | ||||||||
| Expenditure | 64.85-25.9% | 87.56+29.8% | 67.47+27.8% | 52.80+24.9% | 42.26+49.1% | 28.34+9.2% | 25.96+0.0% | 25.96 |
| PROFIT | ||||||||
| Net Profit | -56.89+28.0% | -79.06-31.3% | -60.20-37.4% | -43.81-27.2% | -34.45-68.8% | -20.41-8.0% | -18.90+0.0% | -18.90 |
| KEY METRICS | ||||||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -0.64+28.9% | -0.90-26.8% | -0.71-24.6% | -0.57-26.7% | -0.45-50.0% | -0.30-7.1% | -0.28+0.0% | -0.28 |
Corporate Events
Board MeetingCGON
20264Jun
Board Meeting
Results of the 2026 Annual Meeting of Stockholders, includin…
SEC Filing ↗ Board MeetingCGON
202620May
Board Meeting
President & COO Ambaw Bellete's separation and President Art…
SEC Filing ↗ Board MeetingCGON
202613Apr
Board Meeting
CFO Appointment — Jim DeTore appointed as Chief Financial Of…
SEC Filing ↗